HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance In Brief

This article was originally published in The Rose Sheet

Executive Summary

ProCyte acquisition: Montgomeryville, Penn.-based PhotoMedex announces plans Dec. 1 to purchase dermatological skin care marketer ProCyte in a stock-for-stock transaction estimated at $24.4 mil. Subject to customary terms and conditions including stockholder approval, the transaction is expected to close in the first quarter. PhotoMedex will issue .6622 shares of its common stock in exchange for each outstanding share of ProCyte common stock; the firm expects to issue approximately 10.5 mil. shares total of common stock. CIBC World Markets and Wells Fargo Securities are acting as financial advisors. ProCyte, which markets copper peptide compounds to skin care companies such as Neutrogena in addition to marketing its own skin care lines in doctors' offices, reported revenues of $12 mil. for the 12 months ended Sept. 30. Acquisition gives PhotoMedex entry into aesthetic dermatology market, offering a substantial growth opportunity, according to the firm, which sells contract procedures to hospitals and doctors' offices in a range of specialties, including dermatology...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS012652

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel